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Copper is required for the function of several
cuproenzymes; therefore, its presence is essen-
tial for different physiological functions
(Linder 1991). Cu, however, is able to gener-
ate free radicals and oxidize cellular compo-
nents through its redox activity (Aust et al.
1985). These conﬂicting properties demand a
close regulation of the metal at the organism
level. Effects associated with severe lack or
excess Cu are well described in genetic condi-
tions, such as Menkes disease (Chelly et al.
1993; Mercer et al. 1993; Tanzi et al. 1993;
Vulpe et al. 1993) and Wilson’s disease (Bull
et al. 1993; Tanzi et al. 1996). In contrast,
much less is known about relevant biological
effects associated with situations when no
excess or deﬁcit of Cu is present (Davis 2003;
Hambidge 2003). It is well known that serum
ceruloplasmin (Cp) and Cu values are higher
in young children and increase during even
mild inflammatory/infectious processes, but
their relationships to Cu intake and markers
of Cu status are not clear, and available data
suggest that they modify only when exposure
changes by several orders of magnitude (Araya
et al. 2003b, 2003c). It is still not clear
whether marginal or moderate changes in Cu
exposure may result in adverse effects to
human health because there are no sensitive
indicators of marginal changes in Cu status
and because early functionally relevant
responses are not well deﬁned.
With the aim of improving our under-
standing about the early effects of Cu on
human health, we have conducted a series of
studies on asymptomatic adults undergoing
controlled Cu exposure. This varied between
approximately 3 and 10 times the customary
dietary intake. Clinical trials showed that nau-
sea is the earliest and most frequent response,
and we used the generated data to calculate
the dose–response curve to acute Cu exposure
(Araya et al. 2003a, 2003b, 2003c; Olivares
et al. 2001; Pizarro et al. 2001). A community
survey in which participants ingested between
0.9 and 10 mg Cu/day for 2 months [the con-
centration defined as tolerable daily intake
(TDI) of Cu ingestion for humans; Araya
et al. (2003c)] allowed us to describe the full
range of responses to Cu exposure, showing
that there are more gastrointestinal responses
(mainly nausea) with increasing Cu exposure
(Cu concentration in water) and that these
responses diminish with time, suggesting
adaptation (Araya et al. 2004). In all of these
studies, the statistical analyses suggested that
the variable sex inﬂuenced the results.
No changes in biochemical blood parame-
ters were detected in a previous study in
which healthy participants were exposed to up
to 6 mg Cu/L water, which represented as
much as 14 mg Cu/day on occasional days
depending on the volume of fluids ingested
(Araya et al. 2003c). To further assess the
homeostatic responses to Cu exposure, in a
recent study we assessed the effects of exposing
asymptomatic adults grouped by their Cp val-
ues to the TDI for 2 months, administered as
a single daily supplement. A series of bio-
chemical responses of blood and urinary
potential Cu indicators were measured, and
their detailed analysis will be reported else-
where (Araya et al. unpublished data). The
existing evidence is insufﬁcient to determine
the appropriateness of the different indicators
proposed to assess Cu status among appar-
ently normal individuals; in this article we
present a multivariate strategy to evaluate a
series of proposed indicators for their capacity
to identify differences within the apparently
healthy group. We performed our analysis as a
function of sex, including the relative impor-
tance of each measurement before and after a
Cu supplementation period.
Materials and Methods
The study was a prospective controlled trial in
healthy adults. Participants were 18–50 years
of age, and approximately 50% were younger
and older than 30 years of age. One-half of
them were women who were not pregnant and
did not get pregnant throughout the study.
The need for volunteers was advertised in the
southeastern area of Santiago; potential partici-
pants received detailed information about the
protocol, and those who agreed to participate
signed an informed consent before we formed
the study groups. The Committee on Ethics
for Human Research, Institute of Nutrition
and Food Technology, University of Chile,
approved the protocol. All individuals received
10 mg Cu/day administered under direct
supervision as two gelatin-coated 5-mg Cu
tablets (as Cu sulfate). This dose was chosen
based on two criteria. First, Pratt et al. (1985)
showed no signiﬁcant changes in hematocrit,
triglycerides, serum glutamic oxaloacetic trans-
aminase (GOT), gamma glutamyltransferase
(GGT), lactate dehydrogenase, cholesterol, or
alkaline phosphatase in adult humans after
administering 10 mg Cu/day as Cu gluconate
or placebo capsules for 12 weeks. Second, the
upper limit (10 mg Cu/day) is deﬁned as the
maximum intake from food, water, and sup-
plements that is unlikely to pose risk of adverse
health effects from excess Cu in almost all
(97.5%) apparently healthy individuals, in an
age- and sex-specific population group
(Institute of Medicine 2001). We hypothe-
sized that individuals may have a differential
response to Cu supplementation depending on
their position in the serum Cp distribution
curve, considering a lower value as an index of
long-term low intake. Dietary surveys assessing
total daily Cu intake from food and water in
Chile have revealed that 16.4% of men and
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Research Article33.3% of women between 20 and 60 years of
age are below the estimated average require-
ments (Olivares et al. 2004). Accordingly,
800 apparently healthy individuals were
screened for their serum Cp protein, and
82 individuals that represented the 10%
higher (high-Cp group) and 10% lower
(low-Cp group) values in the Cp distribution
curve were assessed (n = 41 for each group).
Inclusion criteria were a) being free of acute
infectious/inﬂammatory processes (C-reactive
protein < 0.8, as indicated by the kit manu-
facturer; b) white cell count in a hemogram
< 12,000 cells/mL, the lower limit of the nor-
mal range (Dallman 1977) for chronic ill-
nesses and for chronic multimedication that
may interfere with the study.
Before and after the 2-month Cu supple-
mentation, we performed blood and urine
studies. These studies included 18 potential
markers of Cu status chosen from published
data and our experience. Studies in blood
included measurement of Cu in serum by
atomic absorption spectrometry (model 2280;
Perkin Elmer, Norwalk, CT, USA) and in
peripheral mononuclear cells (MNCs; model
SIMAA 6100; Perkin Elmer); Cp protein mea-
sured by nephelometry (array protein system;
Beckman Instruments Inc., Brea, CA, USA);
liver enzymes [serum GOT, serum glutamic-
pyruvic transaminase (GPT), and GGT] deter-
mined using a commercial kit (Boehringer
Mannheim, Mannheim, Germany); homo-
cysteine values determined using an IMX sys-
tem homocysteine kit (Abbott Laboratories,
Diagnostic Division, Abbott Park, IL, USA);
zinc–Cu superoxide dismutase (SOD) activity
in erythrocytes measured by a Bioxytech SOD-
525 Assay (OXIS International Inc, Portland,
OR, USA); and glutathion measured in
peripheral MNCs using a glutathione assay kit
(Calbiochem; Cayman Chemical Company,
Ann Arbor, MI, USA). Studies in urine
included measurement of urinary Cu excretion
after a chelator challenge with 300 mg
2,3-dimercaptopropane-1-sulfonate (DMPS or
Dimaval; Heyl Laboratory, Berlin, Germany),
within 3 days before and after supplementation
beginning and end. Calculating sample size
using α at 5% and power at 80%, we needed
35–45 individuals per group to detect a delta
of 0.5 standard deviations in the biochemical
measurements that were planned.
Data were analyzed using SYSTAT 5.0
(SYSTAT, Inc., Evanston, IL, USA; Wilkinson
1996). All data were log transformed in order
to meet the assumptions of normality of data.
Because study groups were formed on the
basis of individuals’ serum Cp values (high-Cp
and low-Cp), data were ﬁrst assessed by uni-
variate analysis at the beginning and end of
the supplementation period to determine
whether groups formed by individuals’ Cp val-
ues were significantly different. The integral
(multivariate) response to Cu exposure
(defined as the response of all biochemical
measurements at the same time) was explored
by multivariate analysis using principal com-
ponent analysis (PCA) and linear discrimi-
nant analysis (LDA). PCA is a multivariate
statistical tool that simplifies complex data
sets by transforming the original variables into
new independent and uncorrelated variables
named principal components, which explain
the observed variability in decreasing order.
Thus, the ﬁrst components concentrate maxi-
mal information (variance explained) about
the analysis; additionally, for each component
there is an eigenvalue with an associated vari-
ance value (explained variance). On the other
hand, we used LDA as a classification func-
tion to calculate scores for each variable in the
different groups; LDA permits evaluating
whether there are significant relationships
between qualitative variables or classes (in this
case, sex and low-Cp and high-Cp groups)
and quantitative predictor variables (in our
case, eigenvalues of each biochemical vari-
able). Because we knew the classes, we built a
linear discriminant function to estimate the
goodness of this classification within each
class. A matrix originated by PCA served as
the basis for LDA input data; in all analyses,
we added eigenfactors until obtaining close to
80% of variability in the model. Thus, the
LDA output allowed assessing a) whether sex
and Cp levels (low-Cp and high-Cp) differ-
ences are associated with responses to copper;
and b) the integral (multivariate) response of
individuals to Cu exposure. Additionally,
because the discriminant function was applied
to the same sample used to derive it, we used
both cross-validation and jackknife proce-
dures to obtain unbiased estimates (Hair et al.
1992). Using these procedures, we obtained a
classification matrix that allowed evaluating
the performance of the defined classes (sex
and low-Cp and high-Cp groups), verifying
which individuals had high values of correct
classifications. As a control, we also assessed
whether the analyses performed using both
cross-validation and jackknife procedures
yielded the same values of correct classifica-
tions; because no differences were found, we
only show the results of the jackknife matrix.
All the LDA data showed normal multivariate
distribution, which was evaluated using the
Sen and Puri test (Sen and Puri 1968).
Results
Univariate analysis. As expected, Cp values of
individuals grouped by Cp group (low-Cp and
high-Cp) and sex showed signiﬁcant differences
at the beginning [analysis of variance
(ANOVA), Cp group: F = 103.99, df = 1,
p < 0.0001; sex: F = 22.256, df = 1, p < 0.0001;
interaction Cp group × sex: F = 10.591, df =
80, p < 0.002; Figure 1], and end of treatment
(ANOVA, Cp group: F = 126.710, df = 1,
p < 0.0001; sex: F = 22.256, df = 1, p < 0.0001;
interaction Cp group × sex: F = 10.591,
df = 80, p < 0.008; Figure 1).
Multivariate analysis. As a first step, we
explored whether differences existed when all
biochemical measurements were considered at
the same time (integral response), assorting
individuals both by sex and Cp groups. PCA
showed that the first four components
explained 68.62% of the variability; in the
first component, ferritin, GGT, and GPT
obtained the highest loading value (Table 1),
whereas serum Zn and Cu and Cu in MNCs
obtained the lowest values. LDA, using the
matrix obtained from the ﬁrst six PCA com-
ponents (which explained > 80.8% of the
variability observed) and using sex as a classiﬁ-
cation variable, revealed statistically signifi-
cant differences between sexes (Wilks’s
lambda = 0.423; F = 17.043; df = 6, 75;
p < 0.0001). A discriminant classification
matrix showed high values of correct classiﬁ-
cations (80% for men, 88% for women),
indicating that there were differences related
to sex associated with the parameters evalu-
ated. In view of these results, the next analyses
were performed separately on women and
men, before and after Cu supplementation.
Before Cu supplementation. In women,
PCA showed that the first four components
explained 70.6% of the variability. In the ﬁrst
component, ferritin, GGT, and GPT obtained
the highest loading value (Table 2). Among
men, PCA showed that the ﬁrst four compo-
nents explained 70.38% of the variability.
Compared with women, the relative impor-
tance of each element in the ﬁrst component
somewhat differed: GPT and GGT were
included, but not ferritin, and DMPS
(1–4 hr) was among the variables with the
highest loading value (Table 2). The LDA
analysis performed using high- and low-Cp
group as classificatory variables revealed that
these groups were statistically different
(Wilks’s lambda = 0.5136; F = 5.3673;
df = 6, 34; p < 0.0005), showing high values
of correct classifications in the classification
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Figure 1. Cp concentration (media ± SE) in men and
women before and after Cu supplementation
grouped by Cp concentrations of individuals.matrix (low-Cp group, 80%; high-Cp group,
81%). This analysis also shows that although
differences between the Cp groups were signiﬁ-
cant (Wilks’s lambda = 0.660; F = 2.919;
df = 6, 34; p < 0.020), the values of correct clas-
siﬁcations were lower in men than in women
(low-Cp group, 70%; high-Cp group, 67%).
After Cu supplementation. In women,
PCA showed that the first four components
explained 73.27% of the variability. In the
ﬁrst component, as before, Cu supplementa-
tion, GGT, ferritin, and GPT obtained the
highest loading value (Table 2). The LDA
showed signiﬁcant differences between the Cp
groups (Wilks’s lambda = 0.574; F = 4.074;
df = 6, 33; p < 0.0003) and a classification
matrix with values of correct classifications
> 50% (low-Cp group, 76%; high-Cp group,
68%). Among men, PCA showed that the
first components explained 65.91% of the
variability. In the first component, GGT,
GPT, and GOT showed the highest loading
value, showing that in comparison with
analysis before Cu supplementation, GOT
replaced DMPS (1–4 hr; Table 2). LDA in
men also showed differences between Cp
groups (Wilks’s lambda = 0.584; F = 2.496;
df = 8, 32; p < 0.016), and as in the case of
women, values of correct classifications were
> 50% (low-Cp group, 60%; high-Cp group,
67%). Both in women and in men, the per-
centages of correct classiﬁcation were lower in
comparison with the figures obtained before
Cu supplementation.
Discussion
It is well known that serum Cp and Cu vary
responding to rather minor inﬂammatory and
infectious events; at the same time, these indi-
cators are used to assess changes in Cu status in
pathological situations. To what extent they
may reﬂect mild yet relevant changes of Cu sta-
tus among apparently healthy individuals is
still a matter of debate (Araya et al. 2003b,
2003c; Davis 2003; Hambidge 2003; Kehoe
et al. 2000). In this study, participants were
healthy and remained clinically healthy during
the 2-month controlled Cu exposure. Serum
activities of aminotranferases are the traditional
biochemical blood measurements used clini-
cally to assess liver function. Participants
received a daily Cu dose deﬁned as the upper
safe limit for human consumption, so toxic
responses were not expected; liver amino-
tranferases were evaluated to satisfy ethical con-
siderations. We detected no responses that may
represent toxic effects of the Cu dose used. 
Both the univariate and bivariate analyses
support the idea that Cp values in serum repre-
sented a reliable indicator of Cu status respond-
ing to chronic Cu exposure and that sex was
indeed a factor that modulated the response. It
is interesting that both in women and in men
and both before and after Cu supplementation,
GGT and GPT were always included in the ﬁrst
component with high loading values; ferritin
was included only among women, whereas uri-
nary Cu excretion after DMPS challenge was
included among men. Because it is difﬁcult to
interpret these differences with the present data
and there is little experience with DMPS chal-
lenge among normal populations, these ﬁndings
deserve further research. The LDA also showed,
both in women and in men, that the biochemi-
cal indicators measured were signiﬁcantly associ-
ated with the Cp values; the classiﬁcation matrix
showed that the correct assignment values were
higher among women (~ 80%), whereas among
men they reached values of about 70%, suggest-
ing that the Cp value is a good indicator to sepa-
rate the groups, and a reliable descriptor of the
integral response to Cu exposure, but it may be
more sensitive for women that for men.
By the end of the Cu exposure period, in
both sexes the first four PCA components
explained a lower proportion of variance
(73.3% in women and 65.9% in men), sug-
gesting that variability increased in the groups
after Cu supplementation. It is intriguing
that, among women, ferritin decreased its
loading value whereas GGT became the most
relevant variable (Table 2). Among men,
GGT is also the main variable explaining the
variance, and the three transaminases as a
whole (GGT, GPT, and GOT) are the fac-
tors with the highest loading values. This is a
relevant ﬁnding because these enzymes classi-
cally change in hepatic diseases, but it is not
clear that they respond to subclinical situa-
tions (Cashman et al. 2001; Jones et al. 1997;
Lowe et al. 2002; Nayak et al. 2003; Olusi
et al. 2003); even accepting that they may
Article | Méndez et al.
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Table 1. Values (loadings) in the ﬁrst four PCAs for each of the 18 variables assessed in adult individuals
before Cu supplementation.
Variables PC1 PC2 PC3 PC4
Hemoglobin 0.104 0.049 –0.184 –0.018
Ferritin 1.347 0.077 –2.606 1.396
Homocysteine 0.127 –0.104 –0.177 –0.719
Serum Cu –0.003 0.418 0.917 –0.300
Serum Fe 0.169 0.578 –0.365 –0.397
Serum Zn –0.003 0.002 –0.086 0.247
Cu in MNC –0.005 –0.066 0.130 0.075
Fe in MNC –0.013 –0.143 0.128 –0.294
Zn in MNC 0.017 –0.099 –0.023 –0.105
GOT 0.542 –0.437 1.328 0.929
GPT 0.945 –1.187 1.111 1.372
GGT 1.680 0.659 1.342 –1.571
SOD 0.223 0.264 0.395 1.491
DMPS 0.261 2.124 –0.240 0.025
DMPS 0–4 hr –0.333 0.502 0.782 2.621
DMPS 5–24 hr –0.052 0.830 0.619 –0.217
DMPS 0–24 hr –0.318 1.199 0.443 1.185
Urinary Cu 0.058 0.648 0.038 0.297
Percent variance explained 29.08 18.11 12.8 9.650
Value for DMPS is Cu excreted during the indicated time period after administration of 300 mg DMPS. 
Table 2. Loadings from the ﬁrst PCAs studied before and after Cu supplementation. 
Before After
Variables Women Men Women Men
Hemoglobin 0.059 0.006  0.021  –0.029
Ferritin 1.161a –0.346 1.553a 0.428
Homocysteine –0.034 –0.147 0.147 0.293
Serum Cu 0.263  0.038  0.295  0.132
Serum Fe 0.132  0.093  0.130  –0.106
Serum Zn 0.006  0.058  –0.033  –0.125
Cu in MNC 0.001  –0.074  0.116  0.090
Fe in MNC –0.005  –0.112  0.076  0.102
Zn in MNC 0.018  –0.094  0.072  0.143
GOT 0.679 –0.993a 0.722 0.870a
GPT 0.848a –1.640a 0.781a 0.885a
GGT 1.656a –1.197a 2.175a 2.540a
SOD 0.326 0.012 –0.152  –0.321
DMPS 0.716 0.908  0.512  0.844
DMPS 0–4 hr 0.165  0.675 
DMPS 5–24 hr 0.104  0.206 
DMPS 0–24 hr –0.229  0.512 0.472  –0.441
Urinary Cu 0.100  0.279  0.497  0.337
Percent variance explained 31.58 29.58 29.57 26.19
Values for DMPS are Cu excreted during the indicated time period after administration of 300 mg DMPS. 
aVariables with highest loading in the ﬁrst component.Article | Ceruloplasmin and sex in copper response
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respond to other illnesses, our results support
their use to monitor potential adverse effects
of Cu in the liver.
Conclusion
We conclude that Cp values in serum represent
a reliable indicator of Cu status and of the host
response to Cu exposure. This information is
relevant to risk assessment studies of Cu effects
in human health and environmental epidemi-
ology. This response depends on sex and also
on the Cp value, such that women with higher
Cp values and men with lower Cp values
exhibit the greatest response. Why women
respond differently than men and why appar-
ently healthy individuals respond differently
depending on their Cp values is not clear;
ongoing studies are currently exploring these
aspects.
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